Peroxisome Proliferator-activated Receptor Agonist [EPC]

900 reported adverse events

Drugs of this class: ELAFIBRANOR

These side effects are most commonly reported by patients taking drugs of the Peroxisome Proliferator-activated Receptor Agonist [EPC] class:

# Side effect Count
0 FATIGUE 100
1 NAUSEA 86
2 PRURITUS 83
3 DIARRHOEA 74
4 PRODUCT DOSE OMISSION ISSUE 72
5 MYALGIA 68
6 CONSTIPATION 65
7 WEIGHT INCREASED 61
8 ARTHRALGIA 57
9 HEADACHE 44
See all common reactions for Peroxisome Proliferator-activated Receptor Agonist [EPC]

Drugs of the Peroxisome Proliferator-activated Receptor Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRODUCT INEFFECTIVE 7 0.0089
1 CREATINE KINASE INCREASED 5 0.0065
2 HEPATIC PAIN 3 0.0007
3 PRODUCT SUPPLY ISSUE 5 0.0007
4 HEPATIC LESION 3 0.0007
5 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
6 CHROMATURIA 14 0.0006
7 LIVER FUNCTION TEST INCREASED 13 0.0006
8 AMMONIA INCREASED 3 0.0006
9 BRAIN FOG 9 0.0006
See all enriched reactions for Peroxisome Proliferator-activated Receptor Agonist [EPC]